» Articles » PMID: 11587919

Role of Nitric Oxide in the Control of Ocular Blood Flow

Overview
Specialty Ophthalmology
Date 2001 Oct 6
PMID 11587919
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

In the recent years it has been recognized that nitric oxide is an important regulator of ocular blood flow. Nitric oxide is involved in the control of basal blood flow in the choroid, optic nerve and the retina. In addition, nitric oxide mediates a number of vasodilator responses in ocular vessels to agonists such as acetylcholine, bradykinin, histamine, substance P and insulin. Nitric oxide also plays a role in hypercapnia-induced vasodilation in the choroid and is a modulator of pressure autoregulation in this vascular bed. Abnormalities of the L-arginine/nitric oxide system have been observed in a variety of ocular diseases including glaucoma, diabetic retinopathy and retinopathy of prematurity. This makes the L-arginine/nitric oxide pathway an attractive target for therapeutic interventions. Additional research is required, particularly in characterizing the role of the three nitric oxide synthase isoforms in the control of ocular perfusion, to implement this concept into the clinical management of ocular diseases.

Citing Articles

Light-sensitive Ca signaling in the mammalian choroid.

Eltanahy A, Aupetit A, Buhr E, Van Gelder R, Gonzales A Proc Natl Acad Sci U S A. 2024; 121(46):e2418429121.

PMID: 39514305 PMC: 11573543. DOI: 10.1073/pnas.2418429121.


Glaucoma: Current and New Therapeutic Approaches.

Lee H, Tsung T, Tsai Y, Chen Y, Lu D Biomedicines. 2024; 12(9).

PMID: 39335514 PMC: 11429057. DOI: 10.3390/biomedicines12092000.


Evaluating the impact of caloric restriction, body mass index and exercise on primary open-angle glaucoma: A review.

Lai J, Mclarnon P, Sheridan C, Vallabh N Eur J Ophthalmol. 2024; 35(2):429-440.

PMID: 39169764 PMC: 11852537. DOI: 10.1177/11206721241274445.


Chemical Insights into Topical Agents in Intraocular Pressure Management: From Glaucoma Etiopathology to Therapeutic Approaches.

Patton G, Lee H Pharmaceutics. 2024; 16(2).

PMID: 38399328 PMC: 10891530. DOI: 10.3390/pharmaceutics16020274.


Carbonic anhydrase, its inhibitors and vascular function.

Garcia-Llorca A, Carta F, Supuran C, Eysteinsson T Front Mol Biosci. 2024; 11:1338528.

PMID: 38348465 PMC: 10859760. DOI: 10.3389/fmolb.2024.1338528.